In this issue of Clinics in Liver Disease, guest editor Robert G. Gish brings his considerable expertise to the topic of Hepatitis B and Hepatitis D. The articles provide state-of-the-art clinical summaries of the advances in Hepatitis B and D, with emphasis on HBV viro-immunology, novel assays, new targets, and tests for HBV and HDV, and more.
Key Features
Contains 13 relevant, practice-oriented topics including Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B; Maternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta Virus; Triple Threat: HDV, HBV, HIV Coinfection; Targeting Hepatitis B Virus DNA Using Designer Gene Editors; and more.
Provides in-depth clinical reviews on Hepatitis B and D, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Robert G. Gish, MD, Professor Medicine at Loma Linda University, Adjunct Professor of Medicine at the University of Nevada , School of Medicine in Las Vegas, Clinical Professor at the University of Nevada Reno School of Medicine, Clinical Professor at the University of California Skaggs School of Pharmacy and Pharmaceutical Sciences
HBV 5 Line Guideline (Proposed):
Test all adults for Hepatitis B with the triple panel: HBsAg, AntiHBc total, AntiHBs
Vaccinate all adults for HBV who are HBV triple panel negative
If HB surface antigen positive, link to HBV DNA quant and Hep delta total antibody
Treat all individuals who are HBV DNA positive
Stage liver disease and start surveillance for liver cancer and other forms of Liver Disease
Please see attached flyer about Dr. Gish's guest editor issue of Clinics in Liver Disease!
30% discount with code CLINICS30
Comments